Test Price
2,800 AEDโ Home Collection Available
GPR143 Gene Ocular Albinism Type I (Nettleship-Falls) Genetic Test in UAE | AED 2,800 | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified NGS & Sanger Confirmation.
- Premium Logistics: Complimentary VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, 8 AMโ11 PM daily.
- Clinical Guidance: Telephonic Post-Test Clinical Correlation by a DHA-Licensed Consultant Medical Geneticist (Lina Osama Zaki Quteineh, DHA 9294403).
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731 before your draw.
Test Overview & Methodology
This comprehensive next-generation sequencing (NGS) assay screens the entire GPR143 gene for pathogenic variants causing Ocular Albinism Type I (Nettleship-Falls). The analysis includes full exon coverage, Sanger confirmation of all clinically significant variants, and MLPA deletion/duplication analysis to detect larger rearrangements. Results are integrated with clinical correlation to support diagnosis, carrier testing, and family planning.
| Specification | DNA Labs UAE | Standard Overseas Labs |
|---|---|---|
| Technology | NGS with Full Exon Coverage + MLPA for Deletions/Duplications | Often Limited to Targeted Panel or Sanger Only |
| Turnaround Time | 3โ4 Weeks (Expedited Options Available) | 6โ8 Weeks typical |
| Result Interpretation | Integrated Clinical Report with Genetic Counseling & Ophthalmology Correlation | Raw VCF/data only, no clinical correlation |
Physician Insight & Safety Protocols
โ Medication Safety Advisory
Do not discontinue any prescribed medication or alter your treatment plan without consulting your physician. This genetic test is diagnostic only and does not constitute a treatment recommendation.
Exclusion Criteria & Emergency Red Flags
- Active ocular infection, recent intraocular surgery (within 6 weeks), or uncontrolled coagulopathy โ postpone sample collection.
- If the patient presents with sudden vision loss, severe photophobia with meningismus, or acute eye pain, seek emergency ophthalmological evaluation before proceeding with genetic testing.
- This test is not suitable for prenatal diagnosis in isolation; prior identification of the familial variant and genetic counseling are required.
- For minors (<18 years), Federal Decree-Law No. 4 of 2016 on Medical Liability mandates parental/guardian informed consent and a genetic counseling session prior to testing.
Patient FAQ & Clinical Guidance
1. What does the GPR143 NGS test detect, and how reliable is the result?
Our test sequences the entire GPR143 gene using NGS and confirms all pathogenic variants by Sanger sequencing, achieving 99.9% diagnostic sensitivity for single nucleotide variants and small indels. MLPA adds detection of larger deletions/duplications, ensuring comprehensive coverage.
2. I am asymptomatic but have a family history of albinism. Can this test predict if I am a carrier?
Yes, as Ocular Albinism Type I follows X-linked inheritance, carrier females can be identified through targeted analysis of the known familial variant identified in an affected male relative. This enables precise reproductive risk assessment and informed family planning.
3. Do I need to fast or stop medications before the blood draw?
No fasting is required for this DNA test. Please continue all prescribed medications as directed by your physician. Inform the phlebotomist about any blood-thinning medications you are taking.
4. How are my genetic data protected after the test?
Your genomic data is encrypted, stored within UAE borders in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Results are shared only with you and your designated physician upon explicit consent.
UAE Regulatory & Data Privacy Adherence
This laboratory service complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All samples are processed under ISO 9001:2015 certification (INT/EGQ/2509DA/3139). Your genomic data remains encrypted, stored within UAE borders, and never shared without explicit, informed consent. DHA Facility License: 1143.
Clinical & Logistical Metadata
| Test Name | GPR143 Gene Ocular Albinism Type I (Nettleship-Falls) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 21โ28 Business Days (Expedited Options Available) |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) โ VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection Available |
| Methodology Used | Next-Generation Sequencing (NGS) + Sanger Confirmation + MLPA Deletion/Duplication Analysis |
| ICD-10-CM Code | E70.310 |
| LOINC Code | 81321-2 |
| DHA Facility License & Laboratory Address | 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians